Our findings suggest that aberrant overexpression of sPD-1 might block the PD-1/PD-L1 inhibitory pathway and may be associated with persistent activation of self-reactive T cells in RA, leading to long-term disease progression. Here, PDCD1 is linked to rheumatoid arthritis.